Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study

Clinical Neurophysiology

Volumn 127, Issue 1, 2016, Pages 369-378

  Kam, J W Y ^a   Brenner, C A ^a   Handy, T C ^a   Boyd, L A ^a   Liu Ambrose, T ^a   Lim, H J ^a,b   Hayden, S ^a   Campbell, K L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Adjuvant chemotherapy; Breast cancer; Cognitive deficits; Mind wandering; P300 ERP; Rest EEG; Sustained attention

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ATTENTION; ATTENTION DISTURBANCE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; PRIORITY JOURNAL; SELF REPORT; TASK PERFORMANCE; WANDERING BEHAVIOR; AGED; BREAST NEOPLASMS; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME FACTOR; TRENDS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ATTENTION; BREAST NEOPLASMS; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MIDDLE AGED; SELF REPORT; TIME FACTORS;

EID: 84926616327     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2015.03.007     Document Type: Article

References (57)

1. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002, 20(2):485-493.
2. Cheyne J.A., Solman G.J.F., Carriere J.S.A., Smilek D. Anatomy of an error: a bidirectional state model of task engagement/disengagement and attention-related errors. Cognition 2009, 111(1):98-113.
3. Babiloni C., Carducci F., Lizio R., Vecchio F., Baglieri A., Bernardini S., et al. Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2013, 34(6):1427-1446.
4. Barron E., Riby L.M., Greer J., Smallwood J. Absorbed in thought: the effect of mind wandering on the processing of relevant and irrelevant events. Psychol Sci 2011, 22(5):596-601.
5. Braboszcz C., Delorme A. Lost in thoughts: neural markers of low alertness during mind wandering. NeuroImage 2011, 54(4):3040-3047.
6. Brezden B.C.B., Phillips K., Abdolell M., Bunston T., Tannock I.F. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000, 18:2695-2701.
7. Britz J., Van De Ville D., Michel C.M. BOLD correlates of EEG topography reveal rapid resting-state network dynamics. NeuroImage 2010, 52(4):1162-1170.
8. Carriere J.S.A., Cheyne J.A., Smilek D. Everyday attention lapses and memory failures: the affective consequences of mindlessness. Conscious Cogn 2008, 17(3):835-847.
9. Chen X., Li J., Ren J., Hu X., Zhu C., Tian Y., et al. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psycho-Oncol 2014, 23(10):1165-1171.
10. Christoff K., Gordon A.M., Smallwood J., Smith R., Schooler W., Posner M.I., et al. FMRI reveals default Experience sampling during and executive network contributions system to mind wandering. Proc Natl Acad Sci U S A 2009, 106:8719-8724.
11. Clementz B.A., Sponheim S.R., Iacono W.G., Beiser M. Resting EEG in first-episode schizophrenia patients, bipolar psychosis patients, and their first-degree relatives. Psychophysiology 1994, 31:486-494.
12. Delorme A., Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Meth 2004, 134(1):9-21.
13. Finnigan S., Robertson I.H. Resting EEG theta power correlates with cognitive performance in healthy older adults. Psychophysiology 2011, 48(8):1083-1087.
14. Ganz P.A., Kwan L., Castellon S.A., Oppenheim A., Bower J.E., Silverman D.H.S., et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013, 105(11):791-801.
15. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 2003, 100(1):253-258.
16. Jansen C.E., Cooper B.A., Dodd M.J., Miaskowski C.A. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 2011, 19(10):1647-1656.
17. Jim H.S.L., Phillips K.M., Chait S., Faul L.A., Popa M.A., Lee Y.H., et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012, 30(29):3578-3587.
18. Kam J.W., Dao E., Farley J., Fitzpatrick K., Smallwood J., Schooler J.W., et al. Slow fluctuations in attentional control of sensory cortex. J Cogn Neurosci 2011, 23(2):460-470.
19. Kam J.W., Handy T.C. The neurocognitive consequences of the wandering mind: a mechanistic account of sensory-motor decoupling. Front Psychol 2013, 4:725.
20. Kam J.W., Xu J., Handy T.C. I don't feel your pain (as much): the desensitizing effect of mind wandering on the perception of others' discomfort. Cogn Affect Behav Neurosci 2014, 14(1):286-296.
21. Killingsworth M.A., Gilbert D.T. A wandering mind is an unhappy mind. Science 2010, 330:932.
22. Kirschner A., Kam J.W., Handy T.C., Ward L.M. Differential synchronization in default and task-specific networks of the human brain. Front Hum Neurosci 2012, 6:139.
23. Klinger E., Cox W. Dimensions of thought flow in everyday life. Imagination Cogn Person 1987, 7:105-128.
24. Kreukels B.P.C., van Dam F.S., Ridderinkhof K.R., Boogerd W., Schagen S.B. Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 2008, 8(1):80-87.
25. Kreukels B.P.C., Hamburger H.L., de Ruiter M.B., van Dam F.S.A.M., Ridderinkhof K.R., Boogerd W., et al. ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol 2008, 119(3):533-541.
26. Kreukels B.P.C., Schagen S.B., Ridderinkhof K.R., Boogerd W., Hamburger H.L., van Dam F.S.A.M. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 2005, 94(1):53-61.
27. Kreukels B.P.C., Schagen S.B., Ridderinkhof K.R., Boogerd W., Hamburger H.L., Muller M.J., et al. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Clin Breast Cancer 2006, 7(1):67-78.
28. Laufs H. Endogenous brain oscillations and related networks detected by surface EEG-combined fMRI. Hum Brain Mapp 2008, 29(7):762-769.
29. Laufs H., Krakow K., Sterzer P., Eger E., Beyerle A., Salek-Haddadi A., et al. Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest. Proc Natl Acad Sci U S A 2003, 100:11053-11058.
30. Lepage C., Smith A.M., Moreau J., Barlow-Krelina E., Wallis N., Collins B., et al. A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. SpringerPlus 2014, 3(1):444.
31. Li S.J., Li Z., Wu G., Zhang M.J., Franczak M., Antuono P.G. Alzheimer Disease: evaluation of a functional MR imaging index as a marker. Radiology 2002, 225(1):253-259.
32. Lindner O.C., Phillips B., McCabe M.G., Mayes A., Wearden A., Varese F., et al. A meta-analysis of cognitive impairment following adult cancer chemotherapy. Neuropsychology 2014, 28(5):726-740.
33. Lund T.R., Sponheim S.R., Iacono W.G., Clementz B.A. Internal consistency reliability of resting EEG power spectra in schizophrenic and normal subjects. Psychophysiology 1995, 32(1):66-71.
34. Mantini D., Perrucci M.G., Del Gratta C., Romani G.L., Corbetta M. Electrophysiological signatures of resting state networks in the human brain. Proc Natl Acad Sci U S A 2007, 104(32):13170-13175.
35. Mason M.F., Norton M.I., Van Horn J.D., Wegner D.M., Grafton S.T., Macrae C.N. Wandering minds: the default network and stimulus-independent thought. Science 2007, 315(5810):393-395.
36. McVay J.C., Kane M.J., Kwapil T.R. Tracking the train of thought from the laboratory into everyday life: an experience-sampling study of mind wandering across controlled and ecological contexts. Psychon B Rev 2009, 16(5):857-863.
37. O'Connell R.G., Dockree P.M., Robertson I.H., Bellgrove M.A., Foxe J.J., Kelly S.P. Uncovering the neural signature of lapsing attention: electrophysiological signals predict errors up to 20 s before they occur. J Neurosci 2009, 29(26):8604-8611.
38. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2009, 118(10):2128-2148.
39. Pullens M.J., De Vries J., Roukema J.A. Subjective cognitive dysfunction in breast cancer patients : a systematic review. Psychooncology 2010, 19:1127-1138.
40. Quesnel C., Savard J., Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 2009, 116(1):113-123.
41. Robertson I.H., Manly T., Andrade J., Baddeley B.T., Yiend J. "Oops!": performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 1997, 35(6):747-758.
42. Schagen S.B., van Dam F.S., Muller M.J., Boogerd W., Lindeboom J., Bruning P.F. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999, 85(3):640-650.
43. Schagen S.B., Hamburger H.L., Muller M.J., Boogerd W., van Dam F.S. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neuro-oncol 2001, 51(2):159-165.
44. Sherwin B.B., Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996, 81(7):2545-2549.
45. Smallwood J., Beach E., Schooler J.W., Handy T.C. Going AWOL in the brain: mind wandering reduces cortical analysis of external events. J Cogn Neurosci 2008, 20(3):458-469.
46. Smallwood J., Davies J.B., Heim D., Finnigan F., Sudberry M., O'Connor R., et al. Subjective experience and the attentional lapse: task engagement and disengagement during sustained attention. Conscious Cogn 2004, 13(4):657-690.
47. Smallwood J.M., Baracaia S.F., Lowe M., Obonsawin M. Task unrelated thought whilst encoding information. Conscious Cogn 2003, 12(3):452-484.
48. Sonuga-Barke E.J.S., Castellanos F.X. Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis. Neurosci Biobehav Rev 2007, 31(7):977-986.
49. Sponheim S.R., Clementz B.A., Iacono W.G., Beiser M. Clinical and biological concomitants of resting state EEG power abnormalities in schizophrenia. Biol Psychiatry 2000, 48:1088-1097.
50. Sponheim S.R., Clementz B.A., Iacono W.G., Beiser M. Resting EEG in first episode and chronic schizophrenia. Psychophysiology 1994, 31:37-43.
51. Stam C.J., Van Cappellen van Walsum A.M., Micheloyannis S. Variability of EEG synchronization during a working memory task in healthy subjects. Int J Psychophysiol 2002, 46(1):53-66.
52. Tager F.A., McKinley P.S., Schnabel F.R., El-Tamer M., Cheung Y.K.K., Fang Y., et al. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 2010, 123(1):25-34.
53. Thibodeau R., Jorgensen R.S., Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J Abnorm Psychol 2006, 115(4):715-729.
54. van Dam F.S.A.M., Schagen S.B., Muller M.J., Boogerd W., Wall E., Fortuyn M.E.D., et al. Impairment of Cognitive Function in Women receiving adjuvant treatment for high-risk breast cancer: high dose versus standard dose chemotherapy. J Natl Cancer Inst 1998, 90(3):210-218.
55. Wefel J.S., Kesler S.R., Noll K.R., Schagen S.B. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 2015, 65:123-138.
56. Wefel J.S., Vardy J., Ahles T., Schagen S.B. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011, 12(7):703-708.
57. Weissman D.H., Roberts K.C., Visscher K.M., Woldorff M.G. The neural bases of momentary lapses in attention. Nat Neurosci 2006, 9(7):971-978.